FDA panel backs much-debated ALS drug in rare, 2nd review

A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig's disease, a remarkable turnaround for the much-debated medication that was previously rejected by the same group earlier this year.

source https://medicalxpress.com/news/2022-09-fda-panel-much-debated-als-drug.html